Show All Results
Drew Young is the Senior Vice President of Neurology & Immunology (N&I) at EMD Serono. In this role, Drew is responsible for leading the sales and marketing strategy for all N&I products in the U.S.
Working in the pharmaceutical and biotech industry for more than 25 years, Drew has significant experience leading commercial teams across various therapeutic areas and geographies with an expertise in the N&I space. He has achieved success in establishing business operations and driving product performance.
Drew joined EMD Serono in 2014 as Senior Vice President, U.S. Neurology and Immunology where he generated new organizational confidence across the business while regaining market leadership in the interferon category.
He then served as Managing Director in Australia and New Zealand where he grew the corporate footprint, leading two launch preparations, one in N&I and one in oncology and identifying opportunities to expand the Fertility portfolio while strengthening relationships with key government influencers and advocacy partners. Most recently, as Global Commercial Head for the newest product in the global MS franchise, he created operating plans for top global markets and provided guidance to improve payer access in select countries.
Prior to EMD Serono, Drew held a Marketing leadership role on the Neurology team at Biogen. In addition to working for Novartis and Schering, Drew spent over 15 years at Bristol-Myers Squibb in marketing and sales roles that supported the CV and Metabolic areas as well as positions in medical communications, market access and policy development.
He graduated from McGill University with a bachelor’s degree in Business and Managerial Economics.